Catalyst Wire Dossier Catalyst Wire Dossier

Ursodiol 500 mg (Formulation A)

ursodeoxycholic acid · Daewoong Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ursodiol 500 mg (Formulation A), covering 2018-05-07 to 2018-05-07. Get the full timeline:

Most recent: Clinical Trial Update: A Single-dose, Comparative Bioavailability Study of Two Formulations of Ursodiol 500mg Tablets Under Fed Conditions [Phase 1]

See pricing